Nelson, A. J., O’Brien, E., Kaltenbach, L. A., Green, J., Lopes, R. D., Morse, C. G., … Granger, C. B. (2021). Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States. In CIRCULATION (Vol. 144).

Nelson, Adam J., Emily O’Brien, Lisa A. Kaltenbach, Jennifer Green, Renato D. Lopes, Caryn G. Morse, Hussein Al-khalidi, et al. “Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States.” In CIRCULATION, Vol. 144, 2021.

Nelson AJ, O’Brien E, Kaltenbach LA, Green J, Lopes RD, Morse CG, et al. Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States. In: CIRCULATION. 2021.

Nelson, Adam J., et al. “Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States.” CIRCULATION, vol. 144, 2021.

Nelson AJ, O’Brien E, Kaltenbach LA, Green J, Lopes RD, Morse CG, Al-khalidi H, Aroda V, Cavender MA, Gaynor T, Kirk J, Lingvay I, Magwire M, McGuire DK, Pak J, Pop-Busui R, Richardson C, Senyucel C, Kelsey M, Pagidipati NJ, Granger CB. Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States. CIRCULATION. 2021.